Literature DB >> 11348831

Impact of contrast sensitivity performance on visually presented neurobehavioral tests in mercury-exposed children.

P Grandjean1, R F White, K Sullivan, F Debes, K Murata, D A Otto, P Weihe.   

Abstract

Presentation of neuropsychological tests on a computer screen may involve a visual challenge to the examinee. The possible need for adjustment for visual contrast sensitivity on test performance was therefore determined from data on 917 mercury-exposed children who were examined at age 7 years. Contrast sensitivity was found to be associated with performance on the computer-assisted Continuous Performance Test. However, it showed similar associations with performance on traditional pencil-and-paper tests, especially Bender Visual Motor Gestalt Test and Wechsler Intelligence Scale for Children-Revised (WISC-R) Block Designs. Contrast sensitivity was not associated with prenatal mercury exposure, and adjustment for visual function had only a negligible effect on the regression coefficients for mercury as predictor of neuropsychological deficits. The mercury-associated neurobehavioral deficits are therefore unlikely to be due to mercury-induced visual system dysfunction causing secondary deficits in cognitive domain testing. Visuospatial processing appears to be a determinant in contrast sensitivity performance, and careful consideration of whether to control for contrast sensitivity in future studies of neurotoxicant effects is therefore recommended.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348831     DOI: 10.1016/s0892-0362(01)00134-9

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  9 in total

1.  Disruption of dopamine transport by DDT and its metabolites.

Authors:  Jaime M Hatcher; Kristin C Delea; Jason R Richardson; Kurt D Pennell; Gary W Miller
Journal:  Neurotoxicology       Date:  2008-04-29       Impact factor: 4.294

Review 2.  Allelic variation and environmental lead exposure in urban children.

Authors:  Jacquelyn Long; Chandice Covington; Virginia Delaney-Black; Beth Nordstrom
Journal:  AACN Clin Issues       Date:  2002-11

3.  Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system.

Authors:  Jaime M Hatcher; Jason R Richardson; Thomas S Guillot; Alison L McCormack; Donato A Di Monte; Dean P Jones; Kurt D Pennell; Gary W Miller
Journal:  Exp Neurol       Date:  2007-01-05       Impact factor: 5.330

4.  Sensitivity of continuous performance test (CPT) at age 14 years to developmental methylmercury exposure.

Authors:  Jordi Julvez; Frodi Debes; Pal Weihe; Anna Choi; Philippe Grandjean
Journal:  Neurotoxicol Teratol       Date:  2010-08-10       Impact factor: 3.763

5.  Association between polychlorinated biphenyls and Parkinson's disease neuropathology.

Authors:  Jaime M Hatcher-Martin; Marla Gearing; Kyle Steenland; Allan I Levey; Gary W Miller; Kurt D Pennell
Journal:  Neurotoxicology       Date:  2012-08-18       Impact factor: 4.294

Review 6.  Negative confounding in the evaluation of toxicity: the case of methylmercury in fish and seafood.

Authors:  Anna L Choi; Sylvaine Cordier; Pál Weihe; Philippe Grandjean
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

7.  Occupational styrene exposure, colour vision and contrast sensitivity: a cohort study with repeated measurements.

Authors:  Andreas Seeber; Thomas Bruckner; Gerhard Triebig
Journal:  Int Arch Occup Environ Health       Date:  2009-03-29       Impact factor: 3.015

8.  Prenatal and early childhood exposure to tetrachloroethylene and adult vision.

Authors:  Kelly D Getz; Patricia A Janulewicz; Susannah Rowe; Janice M Weinberg; Michael R Winter; Brett R Martin; Veronica M Vieira; Roberta F White; Ann Aschengrau
Journal:  Environ Health Perspect       Date:  2012-07-11       Impact factor: 9.031

Review 9.  Prenatal methylmercury exposure and developmental outcomes: review of the evidence and discussion of future directions.

Authors:  Anne Spurgeon
Journal:  Environ Health Perspect       Date:  2006-02       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.